| Literature DB >> 33573910 |
Brian W Basinski1, Daniel A Balikov2, Michael Aksu2, Qiang Li2, Rajesh C Rao3.
Abstract
Retinal congenital malformations known as microphthalmia, anophthalmia, and coloboma (MAC) are associated with alterations in genes encoding epigenetic proteins that modify chromatin. We review newly discovered functions of such chromatin modifiers in retinal development and discuss the role of epigenetics in MAC in humans and animal models. Further, we highlight how advances in epigenomic technologies provide foundational and regenerative medicine-related insights into blinding disorders. Combining knowledge of epigenetics and pluripotent stem cells (PSCs) is a promising avenue because epigenetic factors cooperate with eye field transcription factors (EFTFs) to direct PSC fate - a foundation for congenital retinal disease modeling and cell therapy.Entities:
Keywords: blindness; development; epigenetics; retina; stem cells
Mesh:
Substances:
Year: 2021 PMID: 33573910 PMCID: PMC8034778 DOI: 10.1016/j.molmed.2021.01.001
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951